Harvey Investment Company’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-88,935
Closed -$18.9M 90
2014
Q4
$18.9M Sell
88,935
-1,094
-1% -$218K 4.4% 5
2014
Q3
$16M Sell
90,029
-1,200
-1% -$199K 4.05% 6
2014
Q2
$15.4M Buy
91,229
+500
+0.6% +$77.8K 3.84% 6
2014
Q1
$11.3M Buy
90,729
+250
+0.3% +$30.4K 2.9% 9
2013
Q4
$10.1M Buy
90,479
+5,725
+7% +$547K 2.67% 9
2013
Q3
$7.67M Buy
84,754
+66,200
+357% +$5.94M 2.17% 17
2013
Q2
$1.56M Buy
+18,554
New +$1.92M 0.47% 45

Other funds holding AGN

Harvey Investment Company's AGN Position: Q1 2015 in Review

Harvey Investment Company sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 88,935 shares — an estimated $18.9M sold.

Harvey Investment Company first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $18.9M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Harvey Investment Company reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Harvey Investment Company sold 88,935 Allergan Inc shares in Q1 2015, an estimated $18.9M.
  • Harvey Investment Company first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Harvey Investment Company's Allergan Inc position peaked at $18.9M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Harvey Investment Company's 13F filing for Q1 2015, filed 23 Apr 2015.